Pretreatment plasma D-dimer and albumin levels were each identified as prognostic factors for several malignancies [23, 24, 27], including ovarian cancer [9, 25]; however, few studies have combined them to assess their role in chemoresistance. This evidence concerns the gene ALB and ovarian cancer.